FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
What's New in Dockets

Posted on October 25, 2004

  • 2004P-0059: HEALTH CLAIM PETITION: GLUCOSAMINE AND CHONDROITIN SULFATE AND OSTEOARTHRITIS
    • Posted CP1, ACK1, SUP1 -3, LET1-7, LET1-5, PDN1, MM1, MT1, ANS1
  • 2004Q-0100: Qualified Health Claim (QHC) Calcium and Bone Fractures
    • Posted LET3, 4
  • 2004N-0214: PUBLIC INFORMATION REGULATIONS
    • Posted EC1, EMC1, 2, NPR1, NFR1
  • 2004Q-0098: Qualified Health Claim: Calcium and Hypertension
    • Posted LET5, 6, SUP1
  • 2004P-0060: HEALTH CLAIM PETITION: GLUCOSAMINE SULFATE AND OSTEOARTHRITIS
    • Posted CP1, EXT1, LET1-10, PDN1, SUP1, EMC1
  • 2004Q-0099: QUALIFIED HEALTH CLAIM: CALCIUM AND MENSTRUAL DISORDERS
    • Posted LET3,4

Posted on October 21, 2004

  • 2004Q-0097: Qualified Health Claim (QHC) Calcium and Cancer
    • Posted ANS1, C1, EC1, EXT1, LET3-4
  • 1995S-0316: 75-Day Premarket Notifications for New Dietary Ingredients
    • RPT 24, 36, 37

Posted on October 19, 2004

  • 2004Q-0144: Qualified Health Claim (QHC): Chromium Picolinate and Diabetes
    • C1, EC3, LET1-3
  • 2004Q-0102: Qualified Health Claim (QHC) Calcium and Kidney/Urinary Stones
    • LET3-4, SUP1, EMC1-2
  • 2004P-0297: NUTRIENT CONTENT CLAIM: DEFINE TERMS LOW CARBOHYDRATE, REDUCED CARBOHYDRATE AND CARBOHYDRATE FREE
    • CP1, ACK1, LET1

Posted on October 5, 2004

  • 2003P-0274:: IN RE TIER 1 INITIAL APPROVAL PROGRAM
  • 2004F-0374: AMEND FOOD ADDITIVE REGULATIONS IN 172.380 VITAMIN D3 TO PERMIT THE USE OF VITAMIN D3 IN CHEESE AND CHEESE PRODUCTS AT A LEVEL ABOVE THAT PERMITTED UNDER 184.1950 VITAMIN D
    • Posted NFL1, C1-2
  • 2004D-0283: WAIVERS OF IN VIVO DEMONSTRATION OF BIOEQUIVALENCE OF ANIMAL DRUGS IN SOLUBLE POWDER ORAL DOSAGE FORM PRODUCTS AND TYPE A MEDICATED ARTICLES
    • Posted GDL1, NAD1, EXT1
  • 2004N-0355: SCIENTIFIC CONSIDERATIONS RELATED TO DEVELOPING FOLLOW-ON PROTEIN PRODUCTS
    • Posted EMC1, EC1-8, C1, NCR1, NM1

Posted on October 4, 2004

  • 2004N-257: Recordkeeping Requirements for Human Food and Cosmetics Manufactured from Processed with, or Otherwise Containing Material from Cattle
    • Posted BKG1, C1-15, EMC1-18, EC1-2, REF1, NPR1

Posted on September 28, 2004

  • 2003N-0312: Discussion of Animal Feed Safety System (AFSS): A Comprehensive Risk-Based Safety Program for the Manufacture and Distribution of Animal Feeds
    • Posted C7, EC1-13, EMC4

Posted on September 27, 2004

  • 2004S-0170: Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Section 1013: Suggest Priority Topics for Research
    • Posted C3-5, EMC24-26

Posted on September 24, 2004

Posted on September 21, 2004

  • 2004S-0212: Pandemic Influenza Preparedness and Response Plan
    • Posted BKG1, N1

Posted on September 16, 2004

  • 95S-0316: 75-Day Premarket Notifications for New Dietary Ingredients
    • RPT221-235

Posted on September 15, 2004

  • 2004S-0233: Stimulating Innovation in Medical Techologies
    • Posted BKG1, C1-17, EC1-15, EMC11-4, N1
  • 2004N-0330: Suicidality in Clinical Trials for Antidepressant Drugs in Pediatric Patients
    • Posted NM1, NCR1, SUP1, C1-2, EC1-21, TS1-2
  • 2004N-0337: Subpart D IRB Referral, Effects of a Single Dose of Dextroamphetamine in Attention Deficit Hyperactivity Disorder; a Functional Magnetic Resonance Study
    • Posted N1, NM1, EC1-2
  • 2004N-0221: Medicare Prescription Drug, Improvement, and Modernization Act of 2003 Section 107(F) B
    • Posted N1, EMC1-24, EC1-25, LET1

Posted on September 13, 2004

  • 2004N-0133: Part II, Electronic Record; Electronic Signatures; Public Meeting
    • Posted C11-35, EMC42-74

Posted on September 8, 2004

  • 2004N-0181: Critial Path Initiative
    • Posted C1-59, EC1-39, EMC1-16

Posted on August 30, 2004

  • 2002N-0278: Section 307:  Bioterrorism Preparedness; Prior Notice of Imported Food Shipment
    • Posted MM13, EC488

Posted on August 9, 2004

  • 2002N-0278: Section 307:  Bioterrorism Preparedness; Prior Notice of Imported Food Shipment
    • Posted C323-364, EMC202-226, EC484-505, EXT2 &3, CR2,
  • 2004S-0270: Notice Announcing Publication of the Report to Congress Entitled "Plan for the Transfer of Responsibility for Medicare Appeals" and Soliciting Comments
  • 1995S-0316: 75-Day Premarket Notifications for New Dietary Ingredients
    • Posted RPT201 through RPT220

Posted on July 20, 2004

  • 1994N-0012: Methods of the Allergenic Products Testing Laboratory
  • 1995S-0316: 75-Day Premarket Notifications for New Dietary Ingredients
    • Posted RPT197 through RPT200

Posted on July 15, 2004

  • 95S-0316: 75-Day Premarket Notifications for New Dietary Ingredients
    • Posted RPT192 through RPT196
  • 2004N-0033: Factor VIII Inhibitors, Public Workshop

Posted on July 13, 2004

  • 95S-0316: 75-Day Premarket Notifications for New Dietary Ingredients
    • Posted RPT189 through RPT191
  • 2004N-0115: Prescription Drug Importation; Public Meeting
    • Posted C28-32
  • 2004Q-0151: Qualified Health Claim (QHC): Soy Protein and Cancer
    • EC1, EMC3,4
  • 2004Q-0180: Qualified Health Claim (QHC): Lutein and Eye Diseases
    • Posted ACK2, EC1-8, 10-12
  • 2004S-0170: Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Section 1013: Suggest Priority Topics for Research
    • Posted EC44-54

Posted on July 1, 2004

  • 2004Q-0201: Qualified Health Claim (QHC); Lycopene, Tomatoes and Cancer
    • Posted QHC2, ACK3

Posted on June 29, 2004

  • 2004N-0133: Part II, Electronic Record; Electronic Signatures; Public Meeting
    • Posted C1-9, EC1-17, EMC1-41, LET1, NM1

Posted on June 9, 2004

  • 2002N-0278: 02N-0278: Bioterrorism Preparedness: Prior Notice of Imported Food Shipments
    • Posted EC386-484, EMC165-201, C294-331, NAD3, NEC1, EXT1

Posted on June 8, 2004

  • 2004N-0115: Prescription Drug Importation; Public Meeting

 

Page Updated October 26, 2004 kk

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility